Genomic and proteomic profiling of responses to toxic metals in human lung cells

Environmental Health Perspectives

Volumn 111, Issue 6, 2003, Pages 825-838

  Andrew, Angeline S ^a,b,c   Warren, Amy J ^a   Barchowsky, Aaron ^a,b,c   Temple, Kaili A ^a,b   Klei, Linda ^a   Soucy, Nicole V ^a   O'Hara, Kimberley A ^a   Hamilton, Joshua W ^a,b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

Author keywords

Arsenic; Cadmium; Chromium; DNA microarray; Hypoxia inducible factor 1 ; Kinase; Mitomycin C; Nickel; Toxicogenomics; Toxicoproteomics

Indexed keywords

ARSENIC; ARSENITE SODIUM; CADMIUM; CADMIUM CHLORIDE; CHROMIUM; DICHROMATE SODIUM; HEAT SHOCK PROTEIN 90; METAL; MITOMYCIN C; NICKEL; NICKEL SUBSULFIDE; RNA;

ANIMAL CELL; BRONCHUS MUCOSA; CELL DEATH; CELL LINE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; EPITHELIUM CELL; EXPOSURE; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC TOXICOLOGY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; RNA ISOLATION; UNINDEXED SEQUENCE;

ANIMALIA; BRONCHUS;

EID: 0037838835     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.111-1241504     Document Type: Review

References (56)

1. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, et al. 1999. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 107:593-597.
2. Alcedo A Wetterhahn KE. 1990. Chromium toxicity and carcinogenesis. Int Rev Exp Pathol 31:85-108.
3. Andrew A, Barchowsky A. 2000. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells. Toxicol Appl Pharmacol 168:50-57.
4. Andrew AS, Karagas MR, Hamilton JW. 2003. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer 104:263-268.
5. Andrew AS, Klei LR, Barchowsky A. 2001. Nickel requires hypoxia-inducible factor-1 alpha, not redox signaling, to induce plasminogen activator inhibitor-1. Am J Physiol Lung Cell Mol Physiol 281:L607-L615.
6. ATSDR. 1998. Toxicological Profile for Chromium. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
7. ATSDR. 1999a. Toxicological Profile for Arsenic. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
8. ATSDR. 1999b. Toxicological Profile for Nickel. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
9. ATSDR. 2001. 1997 CERCLA Priority List of Hazardous Substances. Available: www.atsdr.cdc.gov/97list.html [accessed 14 September 2002].
10. ATSDR. 2002. Toxicological Profile for Cadmium. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
11. Bae DS, Hanneman WH, Yang RS, Campain JA. 2002. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology. Environ Health Perspect 110(suppl 6):931-941.
12. Barceloux DG. 1999. Nickel. J Toxicol Clin Toxicol 37:239-258.
13. Barchowsky A, Lannon BM, Elmore LC, Treadwell MD. 1997. Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos. Environ Health Perspect 105:1131-1137.
14. Barnhart J. 1997. Occurrences, uses, and properties of chromium. Regul Toxicol Pharmacol 26:S3-S7.
15. Bartosiewicz M, Penn S, Buckpitt A. 2001. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ Health Perspect 109:71-74.
16. Baudouin C, Charveron M, Tarroux R, Gall Y. 2002. Environmental pollutants and skin cancer. Cell Biol Toxicol 18:341-348.
17. Beyersmann D, Hechtenberg S. 1997. Cadmium, gene regulation, and cellular signaling in mammalian cells. Toxicol Appl Pharmacol 144:247-261.
18. Byrd DIM, Roegner ML, Griffiths JC, Lamm SH, Grumski KS, Wilson R, et al. 1996. Carcinogenic risks of inorganic arsenic in perspective. Int Arch Occup Environ Health 68:484-494.
19. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15:6269-6279.
20. Chen NY, Ma WY, Huang C, Ding M, Dong Z. 2000. Activation of PKC is required for arsenite-induced signal transduction. J Environ Pathol Toxicol Oncol 19:297-305.
21. Dayan AD, Paine AJ. 2001. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000. Hum Exp Toxicol 20:439-451.
22. Denkhaus E, Salnikow K. 2002. Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Oncol Hematol 42:35-56.
23. Edelman DA, Roggli VL. 1989. The accumulation of nickel in human lungs. Environ Health Perspect 81:221-224.
24. Gebel T. 2000. Confounding variables in the environmental toxicology of arsenic. Toxicology 144:155-162.
25. Gebel TW. 2001. Genotoxicity of arsenical compounds. Int J Hyg Environ Health 203:249-262.
26. Hamadeh HK, Bushel PR, Jayadev S, DiSorbo O, Bennett L, Li L, et al. 2002a. Prediction of compound signature using high density gene expression profiling. Toxicol Sci 67:232-240.
27. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. 2002b. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231.
28. Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA, McCaffrey J, Turpie BW, et al. 1998. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect 106(suppl 4):1005-1015.
29. Hamilton JW, Wetterhahn KE. 1989. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol Carcinog 2:274-286.
30. Hartwig A. 1998. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett 102-103:235-239.
31. Hartwig A, Groblinghoff UD, Beyersmann D, Natarajan AT, Filon R, Mullenders LH. 1997. Interaction of arsenic(III) with nucleoticle excision repair in UV-irradiated human fibroblasts, Carcinogenesis 18:399-405.
32. IARC. 1980. Arsenic and arsenic compounds. IARC Monogr Eval Carcinog Risks Hum 23:39-141.
33. IARC. 1991. Chromium, nickel and welding. IARC Monogr Eval Carcinog Risks Hum 49:1-648.
34. Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, et al. 1997. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin Cancer Res 3:1339-1346.
35. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. 1998. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scandinavian J Work Environ Health 24(suppl 1):1-51.
36. Jelinsky SA, Estep P, Church GM, Samson LD. 2000. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol Cell Biol 20:8157-8167.
37. Kinexus Bioinformatics Corp. 2002. Kinexus. Available: www.kinexus.ca [accessed 14 September 2002].
38. Laden F, Neas LM, Dockery DW, Schwartz J. 2000. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 108:941-947.
39. Leikauf GD. 2002. Hazardous air pollutants and asthma. Environ Health Perspect 110(suppl 4):505-526.
40. Leonard A, Lauwerys RR. 1980. Carcinogenicity, teratogenicity and mutagenicity of arsenic. Mutat Res 75:49-62.
41. Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP. 2001. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61:314-320.
42. Liu Y, Guyton KZ, Gorospe M, Xu Q, Lee JC, Holbrook NJ. 1996. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic Biol Med 21:771-781.
43. McCaffrey J, Wolf CM, Hamilton JA. 1994. Effects of the genotoxic carcinogen chromium(VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinse gene expression in vivo: correlation with glucocorticoid- and developmentally regulated expression. Mol Carcinog 10:189-198.
44. Menzel DB, Rasmussen RE, Lee E, Meacher DM, Said B, Hamadeh H, et al. 1998. Human lymphocyte heme oxygenase 1 as a response biomarker to inorganic arsenic. Biochem Biophys Res Commun 250:653-656.
45. Minet E, Michel G, Mottet D, Raes M, Michiels C. 2001. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 31:847-855.
46. NiPERA. 1999. The Nickel Page. Durham, NC:Nickel Producers Environmental Research Association. Available: www.nipera.org [accessed 14 April 1999].
47. Porter AC, Fanger GR, Vaillancourt RR. 1999. Signal transduction pathways regulated by arsenate and arsenite. Oncogene 18:7794-7802.
48. Ross R. 1971. The smooth muscle cell. J Cell Biol 50:172-185.
49. Rossman TG, Uddin AN, Burns FJ, Bosland MC. 2001. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol 176:64-71.
50. Salnikow K, Blagosklonny MV, Ryan H, Johnson R Costa M. 2000. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60:38-41,
51. Samet JM, Graves LM, Quay J, Dailey LA, Devlin RB, Ghio AJ, et al. 1998. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol 275:L551-L558.
52. Taketani S, Kohno H, Yoshinaga T, Tokunaga R. 1989. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase. FEBS Lett 245:173-176.
53. Vogt BL, Rossman TG. 2001. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - a possible mechanism for arsenite's comutagenicity. Mutat Res 478:159-168.
54. Williams MD, Sandler AB. 2001. The epidemiology of lung cancer. Cancer Treat Res 105:31-52.
55. Wu W, Graves LM, Jaspers I, Devlin RB, Reed W, Samet JM. 1999. Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals. Am J Physiol 277:L924-L931.
56. Yih LH, Peck K, Lee TC. 2002. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23:867-876.